SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
SEC Accession No. 0001193125-22-057928
Filing Date
2022-02-28
Accepted
2022-02-28 16:16:40
Documents
6
Effectiveness Date
2022-02-28

Document Format Files

Seq Description Document Type Size
1 POSASR d280371dposasr.htm POSASR 385202
2 EX-5.1 d280371dex51.htm EX-5.1 34458
3 EX-23.1 d280371dex231.htm EX-23.1 1907
4 EX-FILING FEES d280371dexfilingfees.htm EX-FILING FEES 48088
5 GRAPHIC g280371g0226034050793.jpg GRAPHIC 3993
6 GRAPHIC g280371g61j23.jpg GRAPHIC 32072
  Complete submission text file 0001193125-22-057928.txt   520724
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: POSASR | Act: 33 | File No.: 333-255014 | Film No.: 22689794
SIC: 2836 Biological Products, (No Diagnostic Substances)